C 85

Drug Profile

C 85

Latest Information Update: 23 Sep 1998

Price : $50

At a glance

  • Originator Nonindustrial source
  • Class Antiplatelets
  • Mechanism of Action Cyclooxygenase inhibitors; Platelet aggregation inhibitors; Thromboxane A2 receptor antagonists; Thromboxane B2 antagonists; Thromboxane synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Thrombosis

Most Recent Events

  • 23 Sep 1998 No-Development-Reported for Thrombosis in Taiwan (Unknown route)
  • 13 Nov 1996 New profile
  • 13 Nov 1996 Preclinical development for Thrombosis in Taiwan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top